CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.

Status:
Active, not recruiting

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

Multi-site, non-randomized Phase I/II study involving children and adults.

Phase 1/Phase 2

Peter Bader